[1] PRAUD D,ROTA M,PELUCCHI C,et al.Cigarette smoking and gastric cancer in the Stomach Cancer Pooling (StoP) Project[J].Eur J Cancer Prev,2018,27(2):124-133. [2] LEE Y T,TAN Y J,OON C E.Molecular targeted therapy:Treating cancer with specificity[J].Eur J Pharmacol,2018,834(5):188-196. [3] YANG L,ZHU H,LUO P,et al.Apatinib mesylate tablet in the treatment of advanced malignant melanoma[J].Onco Targets Ther,2018,31(11):5333-5338. [4] 英国和爱尔兰上胃肠道外科医师学会,英国胃肠病学会和英国肿瘤外科学会.食管癌和胃癌治疗指南[J].胃肠病学,2012,17(3):173-175. [5] EISENHAUER E A,THERASSE P,BOGAERTS J,et al.New response evaluation criteria in solid tumours:revised RECIST guideline (version 1.1)[J].Eur J Cancer,2009,45(2):228-247. [6] BOYD M R,PAULL K D.Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen[J].Drug Development Res,2010,34(2):91-109. [7] 左权,向志碧.阿帕替尼在恶性肿瘤治疗中的应用研究进展[J].中国当代医药,2020,27(3):17-20. [8] SCOTT L J.Apatinib:a review in advanced gastric cancer and other advanced cancers[J].Drugs,2018,78(7):747-758. [9] GUOWEI H,YUAN L,MA L,et al.The diagnostic efficacy of CYFRA21-1 on intrahepatic cholangiocarcinoma:a meta-analysis[J].Clin Res Hep Gas,2019,43(3):266-272. [10] 胡泓,龚柳,孙季萍.老年胃癌患者血清肿瘤标志物及细胞因子的表达及意义[J].中国老年学,2018,38(6):1357-1359. [11] 韦维,黄海舸,陆佳明,等.不同病理分期胃癌患者肿瘤标志物,血管内皮生长因子及胃肠激素的变化研究[J].解放军预防医学杂志,2019,37(9):109-111. [12] SMYTH E C,NILSSON M,GRABSCH H I,et al.Gastric cancer[J].Lancet,2020,396(1025):635-648. [13] 孙永福.多西他赛联合替吉奥治疗晚期胃癌的临床观察[J].中国现代医生,2019,57(11):92-94.
2022, Vol. 39 
